Lade Veranstaltungen

EUFEMED Webinar – Subject-centricity in Phase 1 – Expectation, need or obligation?

15. September 2023 @ 16:00 - 17:30
Webinar,
INFORMATION

This is the first of four 2023-2024 EUFEMED webinars. Register for all four now and pay only for three webinars. Dates for the other 3 webinars will be announced in September.

EUFEMED’s Innovation Club is inviting you to the next Webinar - Subject-centricity in Phase 1 – Expectation, need or obligation?

The request from clinical trial participants to be heard and help to improve the clinical trial experience for all participants is significantly increasing. Patient centricity within clinical trials is well advanced and has benefits for both the participants and the sponsors. However, healthy volunteer-centricity is a new concept that is not yet explored. In this webinar we will present existing concepts, first experiences, and the feedback from a EU-wide “volunteers and patients in Phase 1” survey on their needs, expectations and interest to contribute.

Moderator:

  • Ingrid Klingmann, Pharmaplex, AGAH

Speakers:

  • Thijs van Iersel, ICON
  • Dick de Vries, Galapagos (to be confirmed)
  • Jelle Klein, SGS, Healixia

ATTENDANCE FEES (excl. VAT):

  • Member ticket: € 30.00
  • Non-member ticket: € 60.00
  • Webinar series (4 sessions) member ticket € 90.00
  • Webinar series (4 sessions) non-member ticket € 180.00

Member tickets are available for members of: Association of Human Pharmacology in the Pharmaceutical Industry (AHPPI - UK), Healixia (Belgium), Association Française de Pharmacologie Translationnelle (AFPT – France), Association for Applied Human Pharmacology (AGAH - Germany), Associatie van Contract Research Organisaties in Nederland (ACRON - Netherlands), and Polish Federation for Early Medicines Development (Polfemed - Poland)

 

KONTAKT

Verantwortlich für das Programm und die Durchführung

EUFEMED
Rue de l’industrie 4
1000 Brussels
BELGIUM

info@eufemed.eu
www.eufemed.eu

15. September 2023 @ 16:00 - 17:30

EUFEMED Webinar – Subject-centricity in Phase 1 – Expectation, need or obligation?

Webinar